Mustafa Sahin

Credentials: · · · ·

History

Developmental Synaptopathies Associated with TSC, PTEN, SHANK3 and SynGAP1 Pathogenic Variants
National Institute of Neurological Disorders and Stroke · U54
Contact PI · $18.3M · Boston Children's Hospital
2014–2030
Effects of 16p11.2 Copy Number Variation on Neuronal Development and Pathology
National Institute of Mental Health · R01
Contact PI · $3.2M · Boston Children's Hospital
2023–2028
Gene Therapy for Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)
National Institute of Neurological Disorders and Stroke · R33
PI · $342.7K · Boston Children's Hospital
2024–2027
Translational Post-Doctoral Training in Neurodevelopment
National Institute of Mental Health · T32
PI · $2.6M · Boston Children's Hospital
2017–2027

RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome
Principal investigator · Completed · Phase 1, Phase 2
Boston Children's Hospital
2017–2021
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
Principal investigator · Completed · Phase 2
Neuren Pharmaceuticals Limited
2016–2017
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Principal investigator · Completed
Boston Children's Hospital
2013–2020
Treatment of Rett Syndrome With Recombinant Human IGF-1
Principal investigator · Completed · Phase 2
Boston Children's Hospital
2013–2016